A comprehensive meta-analysis conducted by Fang et al. (2018), which included a total of 67 case-control studies, reported the involvement of several CTL4 SNPs and proposed the utility of rs5742909 as predictive genetic biomarker for cancer predisposition (10). This evidence concerns the gene SLC44A4 and cancer.